Pharma Industry News From Medical News Today via MedWorm.com MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Pharma Industry News From Medical News Today' source. Sun, 21 Mar 2010 15:58:19 +0100 Rheumatologists Are Eager To Use Roche-Genentech's ACTEMRA, According To New Study By BioTrends http://www.medworm.com/index.php?rid=3381147&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3z9s BioTrends is pleased to announce the publication of a new syndicated report, LaunchTrends®: ACTEMRA. Actemra (tocilizumab), marketed by Roche-Genentech, is the first IL-6 receptor inhibitor agent approved for rheumatoid arthritis... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3381147 Fri, 19 Mar 2010 10:00:00 +0100 3381147 Quintiles Examines Asia-Pacific Drug Development Landscape In New Report http://www.medworm.com/index.php?rid=3381148&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3z8p As drug makers around the world continue to navigate the complex and ever-changing landscape referred to as the New Health , many companies are flocking to Asia-Pacific for better access to patients, improved operational efficiencies and increasingly, pharmaceutical innovation. In a new report released today, Ferzaan Engineer, Ph.D... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3381148 Fri, 19 Mar 2010 07:00:00 +0100 3381148 Study Finds The Cost Of Cancer Care Is Skyrocketing http://www.medworm.com/index.php?rid=3376413&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3z75 USA Today: "The cost of cancer treatment is 'skyrocketing' - both for individual patients and the nation, a new analysis shows. From 1990 to 2008, spending on cancer care soared to more than $90 billion from $27 billion... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3376413 Thu, 18 Mar 2010 12:00:00 +0100 3376413 Drugmakers Are 'Under-Exposed' In Emerging Markets, Report Says http://www.medworm.com/index.php?rid=3376412&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3z74 Growing markets for pharmaceuticals in China, Brazil, Russia and India are outpacing national markets in Europe and the U.S., but major drugmakers have been slow to expand in these markets and may lose opportunities, a new study finds, The New York Times reports... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3376412 Thu, 18 Mar 2010 12:00:00 +0100 3376412 FDA Advisory Committee Recommends Approval Of InterMune's Esbriet(R) (pirfenidone) For Idiopathic Pulmonary Fibrosis http://www.medworm.com/index.php?rid=3376415&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3z6B InterMune, Inc. (Nasdaq: ITMN) announced that the U.S. Food and Drug Administration's (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) voted 9-3 to recommend approval of Esbriet® (pirfenidone) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3376415 Thu, 18 Mar 2010 11:00:00 +0100 3376415 Protalix Initiates A Phase I Clinical Trial Of Acetylcholinesterase For Biodefense Indications http://www.medworm.com/index.php?rid=3376414&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3z6x Protalix BioTherapeutics, Inc. (NYSE-Amex: PLX) announced that it has initiated a phase I clinical trial of PRX-105, the Company's plant cell expressed pegylated recombinant human acetylcholinesterase product candidate in development for biodefense indications. The trial is designed to study the safety of PRX-105 by administering a bolus intravenous injection of PRX-105 in healthy volunteers... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3376414 Thu, 18 Mar 2010 11:00:00 +0100 3376414 HDMA Recognizes Amerisourcebergen Packaging Group And Pfizer Pharmaceuticals With Inaugural Distribution Management Award http://www.medworm.com/index.php?rid=3372368&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3z4j The Healthcare Distribution Management Association (HDMA) presented its first Distribution Management Award to AmerisourceBergen Packaging Group (ABPG) and Pfizer Pharmaceuticals for its Toviaz™ Physician Sample Package Optimization project... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3372368 Wed, 17 Mar 2010 12:00:00 +0100 3372368 EU-India Free-Trade Negotiations Could Limit Access To Affordable, Generic Drugs, Advocacy Group Says http://www.medworm.com/index.php?rid=3372367&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3z49 The advocacy group Medecins Sans Frontieres (MSF) recently warned that free-trade negotiations between the EU and India could limit access to "affordable generic drugs" for people in India and the rest of the developing world, Reuters reports... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3372367 Wed, 17 Mar 2010 12:00:00 +0100 3372367 Director Of U.S. Patent And Trademark Office To Speak At 2010 BIO International Convention http://www.medworm.com/index.php?rid=3368448&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yYc David Kappos, Director of the U.S. Patent and Trademark Office and Under Secretary of Commerce for Intellectual Property, will be a featured speaker at the Intellectual Property Super Session taking place during the 2010 BIO International Convention... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3368448 Tue, 16 Mar 2010 11:00:00 +0100 3368448 Arcadia Biosciences Completes First Commercial Production Of SONOVA™ 400 High GLA Safflower Oil http://www.medworm.com/index.php?rid=3365077&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yVY Arcadia Biosciences, Inc., an agricultural technology company focused on developing technologies and products that benefit the environment and human health, announced today that it has successfully completed the first commercial production of SONOVA™ 400 High GLA Safflower Oil... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3365077 Mon, 15 Mar 2010 12:00:00 +0100 3365077 FDA Task Force Seeks Public Comments On Increasing Transparency With Regulated Industry http://www.medworm.com/index.php?rid=3363396&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ySR As part of the final phase of its transparency initiative, the U.S. Food and Drug Administration is seeking comment from the public and other interested stakeholders on how the agency can increase transparency in its interactions with regulated industry. Posted in the March 12, 2010, Federal Register, the request for electronic or written comments has a deadline of April 12, 2010... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3363396 Sun, 14 Mar 2010 08:00:00 +0100 3363396 Regulatory Affairs Workload At Drug Development Firms Has Increased Dramatically, According To Tufts Center For The Study Of Drug Development http://www.medworm.com/index.php?rid=3361259&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yRv A growing volume of global drug development and commercialization activity during the past decade has dramatically increased the workload for regulatory affairs professionals at pharmaceutical and biotech companies, according to a study recently completed by the Tufts Center for the Study of Drug Development... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3361259 Fri, 12 Mar 2010 18:00:00 +0100 3361259 PhRMA Spends $6.3 Lobbying In Fourth Quarter, Slight Increase From Year Before http://www.medworm.com/index.php?rid=3356835&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yQJ The Pharmaceutical Research and Manufacturers of America spent $6.3 million lobbying Congress and other government arms on health care in the fourth quarter of 2009, The Associated Press reports. PhRMA "spent just 2 percent more than the $6.17 million it paid out for lobbying in the year-ago period. The group's members include drug giants Pfizer Inc., Merck & Co... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3356835 Fri, 12 Mar 2010 11:00:00 +0100 3356835 CBio Secures Another Clinical Trial Milestone http://www.medworm.com/index.php?rid=3356837&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yQ5 Australian drug development company CBio Limited (ASX: CBZ) announced the achievement of a clinical trial milestone under its option agreement with global pharmaceutical leader Novo Nordisk A/S. The agreement relates to the development of XToll, the potential new-generation drug therapy which could provide safer and more effective treatment of autoimmune diseases such as rheumatoid arthritis (RA)... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3356837 Fri, 12 Mar 2010 10:00:00 +0100 3356837 AstraZeneca Comments On FDA Joint Advisory Committee Meeting On Post-Marketing Safety Studies For The Use Of LABAs In Asthma http://www.medworm.com/index.php?rid=3356836&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yPZ On March 10-11, 2010, the Joint Advisory Committees of the U.S. Food and Drug Administration (FDA) -- including the Pulmonary-Allergy Drugs and the Drug Safety and Risk Management Advisory Committees -- discussed the design of post-marketing safety studies for long-acting beta-agonist (LABA)-containing products in the U.S., including SYMBICORT® (budesonide/formoterol fumarate dihydrate)... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3356836 Fri, 12 Mar 2010 10:00:00 +0100 3356836 BIO Asks Congress To Support Deployment Of Biotech Chemical Platforms To Create Green Jobs http://www.medworm.com/index.php?rid=3356839&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yPH Federal tax policies should incentivize commercial deployment of advanced industrial biotechnologies, which can create jobs, reduce reliance on petroleum, and achieve greenhouse gas reductions... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3356839 Fri, 12 Mar 2010 09:00:00 +0100 3356839 Tougher Action To Support Medicines Supply, UK http://www.medworm.com/index.php?rid=3356838&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yPy A package of tough new actions to ensure that NHS patients can get the medicines they need was agreed at a summit to discuss concerns about current difficulties with the supply of medicines, hosted by Health Secretary Andy Burnham and Health Minister Mike O'Brien yesterday... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3356838 Fri, 12 Mar 2010 09:00:00 +0100 3356838 GSK To Offer Flexible Drug Pricing In Middle-Income Countries http://www.medworm.com/index.php?rid=3356840&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yNx Drug maker GlaxoSmithKline (GSK) "plans to bolster earnings by selling to more people in middle-income countries after cutting prices in the world's poorest nations," Bloomberg/BusinessWeek reports. "Our strategy is to grow our business in middle-income countries by increasing the volume of products we sell," GSK Chief Executive Andrew Witty said by e-mail, according to the news service... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3356840 Thu, 11 Mar 2010 14:00:00 +0100 3356840 FDA Sponsoring Workshops To Increase Rare Disease Treatment Options http://www.medworm.com/index.php?rid=3356841&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yNd The Wall Street Journal: FDA is putting on workshops for pharmaceutical manufacturers to increase the pool of applicants for approved "orphan drugs," that treat rare diseases. Currently, there are about 7,000 so-called orphan diseases in the U.S. that have few or no FDA-approved treatments... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3356841 Thu, 11 Mar 2010 13:00:00 +0100 3356841 Vital Information Missing In Patient Safety Reporting And Drug Label Accuracy http://www.medworm.com/index.php?rid=3352444&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yMB A Perspective piece in the New England Journal of Medicine calls for change in the way researchers and pharmaceutical companies collect and report adverse symptom information in clinical trials submitted to the Food and Drug Administration (FDA), and how the FDA represents this information on drug labels... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3352444 Thu, 11 Mar 2010 11:00:00 +0100 3352444 Dainippon Sumitomo Pharma America Announces FDA Acceptance Of Lurasidone New Drug Application For Treatment Of Schizophrenia http://www.medworm.com/index.php?rid=3352445&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yMf Dainippon Sumitomo Pharma America, Inc. (DSPA), a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP), announced that the U.S. Food and Drug Administration (FDA) recently accepted for review the lurasidone New Drug Application (NDA) for the treatment of patients with acute schizophrenia. The NDA was submitted to FDA on December 30, 2009 and will receive a standard review... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3352445 Thu, 11 Mar 2010 10:00:00 +0100 3352445 Intentional Variation Increases Result Validity In Mouse Testing http://www.medworm.com/index.php?rid=3348731&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yJ9 For decades, the traditional practice in animal testing has been standardization, but a study involving Purdue University has shown that adding as few as two controlled environmental variables to preclinical mice tests can greatly reduce costly false positives, the number of animals needed for testing and the cost of pharmaceutical trials... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3348731 Wed, 10 Mar 2010 10:00:00 +0100 3348731 Research Finds Shortcomings In Comparative Effectiveness Drug Research http://www.medworm.com/index.php?rid=3348732&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yHT An analysis by researchers at the Keck School of Medicine of the University of Southern California (USC) has found that only 32 percent of medication studies published in top medical journals compare the effectiveness of existing treatments. These studies, known as comparative effectiveness studies, help doctors know which therapies work best and under what circumstances they are most effective... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3348732 Wed, 10 Mar 2010 09:00:00 +0100 3348732 William A. Hawkins, Medtronic Chairman And CEO, Receives Distinguished Achievement Award From Biomedical Engineering Society http://www.medworm.com/index.php?rid=3348733&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yHw Medtronic, Inc., (NYSE: MDT), announced William A. Hawkins, chairman and CEO, recently received the Biomedical Engineering Society's Distinguished Achievement Award. As part of the award, the plenary lecture he delivered to the organization was published in the March 2010 edition of the Annals of Biomedical Engineering... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3348733 Wed, 10 Mar 2010 08:00:00 +0100 3348733 Science World Charmed By Snake Venom http://www.medworm.com/index.php?rid=3345041&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yFj The King Cobra continues to weave its charm with researchers identifying a protein in its venom with the potential for new drug discovery and to advance understanding of disease mechanisms. The novel protein named haditoxin has been described in the prestigious Journal of Biological Chemistry (March 12, 2010)... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3345041 Tue, 09 Mar 2010 10:00:00 +0100 3345041 Nektar Announces Positive Phase 2 Clinical Data From First Stage Of NKTR-102 Study In Women With Platinum-Resistant Ovarian Cancer http://www.medworm.com/index.php?rid=3345042&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yDP Nektar Therapeutics (Nasdaq: NKTR) announced preliminary progression-free survival data from the first stage of a two-stage Phase 2 clinical study evaluating single-agent treatment with NKTR-102 in women with platinum-resistant ovarian cancer... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3345042 Tue, 09 Mar 2010 09:00:00 +0100 3345042 Selective Automation A Must For Clinical Labs To Remain Competitive http://www.medworm.com/index.php?rid=3345043&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yDc While clinical laboratories are vital to the diagnostic industry, they are facing multiple challenges that will require increased automation in order for them to remain competitive... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3345043 Mon, 08 Mar 2010 13:00:00 +0100 3345043 InterMune Announces Posting Of Briefing Documents For FDA Advisory Committee Meeting On Pirfenidone http://www.medworm.com/index.php?rid=3337127&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yB4 InterMune, Inc. (Nasdaq: ITMN) announced that the U.S... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3337127 Sat, 06 Mar 2010 09:00:00 +0100 3337127 Poniard Pharmaceuticals Presents Positive Survival Data From A Phase 2 Clinical Study Of Picoplatin In Metastatic Prostate Cancer http://www.medworm.com/index.php?rid=3337126&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yB2 Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC)... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3337126 Sat, 06 Mar 2010 09:00:00 +0100 3337126 FDA Approves Name Change For Heartburn Drug Kapidex http://www.medworm.com/index.php?rid=3337128&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yxJ The U.S. Food and Drug Administration has approved a name change for the heartburn drug Kapidex (dexlansoprazole) to avoid confusion with two other medications - Casodex and Kadian. Effective in late April 2010, Takeda Pharmaceuticals North America Inc. will market Kapidex under the new name Dexilant... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3337128 Sat, 06 Mar 2010 02:00:00 +0100 3337128 2010 BIO International Convention Expected To Bring More Than $25 Million To Chicago http://www.medworm.com/index.php?rid=3337129&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yxy The Biotechnology Industry Organization announced that the 2010 BIO International Convention is expected to contribute more than $25 million to the local economy, according to estimates from the Chicago Convention and Tourism Bureau. The BIO International Convention returns to Chicago May 3-6 and is expected to draw 15,000 to 17,000 industry leaders from 48 states and 60 countries... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3337129 Fri, 05 Mar 2010 19:00:00 +0100 3337129 Gynecologic Oncology Group Notifies CTI That Continuation Of GOG-212 Pivotal Trial Of OPAXIO Maintenance Therapy In Ovarian Cancer Is A Priority http://www.medworm.com/index.php?rid=3333531&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yxp Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced that CTI received a statement on March 1, 2010 from the Gynecologic Oncology Group (GOG) leadership that the phase III GOG-212 clinical trial of CTI's OPAXIO™ used as maintenance therapy for ovarian cancer remains a high priority and enrollment will continue... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3333531 Fri, 05 Mar 2010 12:00:00 +0100 3333531 Key Caldolor(R) Orthopedic Data To Be Presented At American Academy Of Orthopaedic Surgeons' Annual Meeting http://www.medworm.com/index.php?rid=3333530&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yxn Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced that results from a clinical trial of Caldolor® (ibuprofen) Injection will be presented at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) in New Orleans, Louisiana... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3333530 Fri, 05 Mar 2010 12:00:00 +0100 3333530 Medtronic Named Among World's Most Innovative Companies By MIT Technology Review http://www.medworm.com/index.php?rid=3333532&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yv2 Medtronic, Inc. (NYSE: MDT) announced that it has been selected as one of Massachusetts Institute of Technology (MIT) Technology Review's 50 most innovative companies. Known as TR50, the first annual list includes companies that Technology Review believes have demonstrated superiority in inventing technology and in using it both to grow their own business and transform how we live... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3333532 Thu, 04 Mar 2010 22:00:00 +0100 3333532 Dendreon Presents Updated IMPACT Results Confirming PROVENGE Improves Overall Survival In Patients With Metastatic Castrate-Resistant Prostate Cancer http://www.medworm.com/index.php?rid=3329422&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ytd Dendreon Corporation (Nasdaq: DNDN) announced updated results from its pivotal Phase 3 IMPACT (IMmunotherapy for Prostate AdenoCarcinoma Treatment) study demonstrating that PROVENGE® (sipuleucel-T) extends overall survival in men with metastatic, castrate-resistant (hormone-refractory) prostate cancer (CRPC)... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3329422 Thu, 04 Mar 2010 13:00:00 +0100 3329422 Cabazitaxel Increased Survival For Patients With Advanced Hormone-Refractory Prostate Cancer http://www.medworm.com/index.php?rid=3329423&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yt5 Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based chemotherapy... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3329423 Thu, 04 Mar 2010 12:00:00 +0100 3329423 75 Percent Of Drug Companies Formally Manage Investigator-Initiated Trials http://www.medworm.com/index.php?rid=3329424&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ysF Investigator-initiated trials (IITs) provide companies with clinical data to expand scientific understanding of their drugs and reap a number of additional benefits. IIT management, however, can be challenging. Data collected by business intelligence firm Cutting Edge Information show that 75% of surveyed companies have some form of dedicated IIT management group in place... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3329424 Thu, 04 Mar 2010 11:00:00 +0100 3329424 Complete Medical Group Launches Complete Digital At Eyeforpharma, 5th Annual Pharma E-Marketing Summit http://www.medworm.com/index.php?rid=3325281&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yrm Complete Medical Group (CMG) has today launched a new division, Complete Digital, at the eyeforpharma 5th Annual Pharma eMarketing Summit. Complete Digital, led by digital industry expert Kay Wesley, is gold sponsor of the event, aimed at engaging physicians and consumers with innovative eMarketing and social media strategies... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3325281 Wed, 03 Mar 2010 12:00:00 +0100 3325281 Cardio3 BioSciences Announces Promising Pre-Clinical Data For Proprietary C-Cath(R) Catheter http://www.medworm.com/index.php?rid=3325280&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ypy Cardio3 BioSciences, a leading Belgian biotechnology company specialising in cell-based therapies for the treatment of cardiovascular diseases, announced promising results in a pre-clinical study of its proprietary C-Cath(R) catheter which is under development to administer a range of bio-therapeutics to the heart... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3325280 Wed, 03 Mar 2010 12:00:00 +0100 3325280 InterMune Announces Submission Of MAA For Pirfenidone For The Treatment Of Patients With IPF http://www.medworm.com/index.php?rid=3325279&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ypw InterMune, Inc. (Nasdaq: ITMN) announced that it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) seeking approval to market pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the European Union (EU). Currently, there are no EMA-approved treatments for IPF in the EU... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3325279 Wed, 03 Mar 2010 12:00:00 +0100 3325279 Abbott And Enanta Announce Advancement Of Hepatitis C Collaboration http://www.medworm.com/index.php?rid=3325278&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ypr Abbott (NYSE: ABT) and Enanta Pharmaceuticals announced the advancement of their Hepatitis C (HCV) collaboration into Phase 2 clinical trials. The trial will evaluate three HCV antiviral agents, including the investigational protease inhibitor ABT-450, part of the Abbott-Enanta collaboration, and polymerase inhibitors ABT-333 and ABT-072 currently being developed exclusively by Abbott... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3325278 Wed, 03 Mar 2010 12:00:00 +0100 3325278 New Data From Caldolor(R) Study In Burn Patients To Be Presented At 42nd Annual Meeting Of The American Burn Association http://www.medworm.com/index.php?rid=3325277&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ypq Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced that data from a recent study evaluating the safety and efficacy of Caldolor® (ibuprofen) Injection in treating pain and fever in hospitalized burn patients will be presented at the 42nd Annual Meeting of the American Burn Association in Boston... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3325277 Wed, 03 Mar 2010 12:00:00 +0100 3325277 Activists And Lobbyists Ramp Up Efforts In Possible Final Health Care Push http://www.medworm.com/index.php?rid=3325282&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yqh Politico: "In the absence of clear next steps, outside groups have stepped in to beat the drum, keeping time while the leadership meets behind closed doors to write the next movement. ... Progressive advocacy groups like Health Care for America Now and Families USA are organizing supporters and protests across the country, reminding Americans and lawmakers why inaction is unacceptable... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3325282 Wed, 03 Mar 2010 11:00:00 +0100 3325282 One-on-One Partnering Opens Today For The 2010 BIO International Convention Business Forum http://www.medworm.com/index.php?rid=3325284&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ynR The Biotechnology Industry Organization announces that representatives of biotech and pharmaceutical companies, academic research institutions and licensing professionals, as well as investors attending the BIO International Convention Business Forum can now begin to request One-on-One business development meetings through BIO's proprietary partnering system... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3325284 Wed, 03 Mar 2010 10:00:00 +0100 3325284 The European Journal Of Drug Metabolism And Pharmacokinetics To Be Published By Springer http://www.medworm.com/index.php?rid=3325283&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ynp Starting in 2010, Springer will publish the European Journal of Drug Metabolism and Pharmacokinetics. All aspects of drug delivery and bioavailability are covered in the journal, which was previously published by the Swiss publisher Médecine & Hygiène... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3325283 Wed, 03 Mar 2010 10:00:00 +0100 3325283 BIO Joins NORD In Supporting The Goals Of Rare Disease Day http://www.medworm.com/index.php?rid=3325285&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ymc Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement in observance of Rare Disease Day 2010. This event recognizes the profound need for more medical research and the unique partnership that exists between rare disease patients and researchers... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3325285 Wed, 03 Mar 2010 06:00:00 +0100 3325285 BIO Announces New Networking And Collaboration Forum At 2010 BIO International Convention http://www.medworm.com/index.php?rid=3325286&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ym9 The 2010 BIO International Convention will feature the first-ever BIOPark, a hub focused on fostering networking and collaboration among academics, licensing professionals, incubator services, and early-stage companies, announced the Biotechnology Industry Organization (BIO) today... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3325286 Wed, 03 Mar 2010 05:00:00 +0100 3325286 Drugmakers' Business Practices Draw Scrutiny http://www.medworm.com/index.php?rid=3320325&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yjz Three top California Medicaid officials in charge of pharmacy issues failed to disclose trips paid for by drug-industry funded business groups, California Watch/San Francisco Chronicle reports. Officials who are directly involved in setting drug policy and negotiating payments took about 12 trips paid for by these nonprofit business groups... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3320325 Tue, 02 Mar 2010 09:00:00 +0100 3320325 Pharmaceutical Industry Support Not Desirable But Frequently Accepted By Residency Program Directors http://www.medworm.com/index.php?rid=3320326&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yhd Most directors of internal medicine residency training programs would prefer not to accept pharmaceutical support for the residencies they oversee, but more than half report doing so, according to an article in the February 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3320326 Mon, 01 Mar 2010 17:00:00 +0100 3320326 Avastin Phase III Study Shows Positive Results In Women With Advanced Ovarian Cancer http://www.medworm.com/index.php?rid=3313491&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yfN Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that a phase III study showed the combination of Avastin (bevacizumab) and chemotherapy followed by maintenance use of Avastin increased the time women with advanced ovarian cancer lived without their disease worsening (progression-free survival or PFS) compared to chemotherapy alone... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3313491 Sat, 27 Feb 2010 10:00:00 +0100 3313491 U.S. Food And Drug Administration Approves Cayston(R) For The Improvement Of Respiratory Symptoms In Cystic Fibrosis Patients http://www.medworm.com/index.php?rid=3313490&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yfM Gilead Sciences, Inc. (Nasdaq:GILD) announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Cayston(R)(aztreonam for inhalation solution) as a treatment to improve respiratory symptoms in cystic fibrosis (CF) patients with Pseudomonas aeruginosa (P. aeruginosa)... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3313490 Sat, 27 Feb 2010 10:00:00 +0100 3313490 Forest Laboratories Receives Decision From FDA For Supplemental New Drug Application For Bystolic(R) http://www.medworm.com/index.php?rid=3313489&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yfL Forest Laboratories, Inc. (NYSE: FRX) announced that the U.S. Food and Drug Administration (FDA) did not approve the additional indication for Bystolic(R) (nebivolol) tablets as a treatment for stable chronic heart failure (CHF) as requested in the company's Supplemental New Drug Application (sNDA). Bystolic is currently approved in the US for the treatment of hypertension... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3313489 Sat, 27 Feb 2010 10:00:00 +0100 3313489 Shire Announces FDA Approval Of VPRIV(TM) (velaglucerase Alfa For Injection) For The Treatment Of Type 1 Gaucher Disease http://www.medworm.com/index.php?rid=3313492&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3yfm Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for VPRIV, a human cell line derived enzyme replacement therapy (ERT) for the long-term treatment of Type 1 Gaucher disease in pediatric and adult patients... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3313492 Sat, 27 Feb 2010 09:00:00 +0100 3313492 Startup Joins UCLA Tech Incubator To Develop Technologies For Drug Discovery, Screening http://www.medworm.com/index.php?rid=3313493&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ybY Librede Inc. has joined the UCLA on-campus technology incubator space at the California NanoSystems Institute, where the startup company will work on developing technologies to improve ion channel drug discovery and screening. Ion channels are proteins in cell membranes that play a central role in generating and transmitting cardiac and neural signals... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3313493 Sat, 27 Feb 2010 08:00:00 +0100 3313493 Kinex Pharmaceuticals Initiates A Phase 2 Clinical Trial Of KX2-391 In Patients With Prostate Cancer http://www.medworm.com/index.php?rid=3309583&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ybL Kinex Pharmaceuticals opened a Phase 2 clinical trial to evaluate the safety and efficacy of KX2-391 in patients with bone-metastatic, castrate-resistant prostate cancer (CRPC) who have not had prior chemotherapy... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3309583 Fri, 26 Feb 2010 12:00:00 +0100 3309583 Light Sciences Oncology Meets A Major Milestone In Aptocine Development With Target Enrollment In Phase 3 MCRC Trial http://www.medworm.com/index.php?rid=3309582&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3ybK Light Sciences Oncology, Inc. (LSO) announced the achievement of a major milestone in its late-stage clinical development of Aptocine™ (talaporfin sodium) for treatment of solid tumors. LSO's global Phase 3 trial of Aptocine in metastatic colorectal cancer (MCRC) has reached target enrollment of 450 patients at 52 sites... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3309582 Fri, 26 Feb 2010 12:00:00 +0100 3309582 Arena Pharmaceuticals Announces FDA Acceptance Of Lorcaserin NDA For Filing http://www.medworm.com/index.php?rid=3304783&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3y6X Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced that its New Drug Application (NDA) for lorcaserin, Arena's internally discovered and developed drug candidate for weight management, including weight loss and maintenance of weight loss, has been accepted for filing by the US Food and Drug Administration (FDA)... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3304783 Thu, 25 Feb 2010 11:00:00 +0100 3304783 BIO Invites Nominations For The 2010 George Washington Carver Award For Innovation In Industrial Biotechnology http://www.medworm.com/index.php?rid=3304784&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3y5X The third annual George Washington Carver Award will recognize significant contributions by an individual to the field of industrial biotechnology, including applications in biological engineering, environmental science, biorefining and biobased products... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3304784 Thu, 25 Feb 2010 09:00:00 +0100 3304784 Medical News Today And Medilexicon Launch Two Health Forums http://www.medworm.com/index.php?rid=3309584&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3y76 Medical News Today and Medilexicon are proud to announce the launch of two medical health forums, where health care professionals, patients and lay people may discuss a wide range of medical themes. We invite you to have a look at them... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3309584 Thu, 25 Feb 2010 08:00:00 +0100 3309584 Medical News Today And Medilexicon Launch Two Online Medical Health Forums http://www.medworm.com/index.php?rid=3304785&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3y76 Medical News Today and Medilexicon are proud to announce the launch of two medical health forums, where health care professionals, patients and lay people may discuss a wide range of medical themes. We invite you to have a look at them... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3304785 Thu, 25 Feb 2010 08:00:00 +0100 3304785 Americans Living Longer, Healthier Lives Due To Medical Innovation And New Therapies http://www.medworm.com/index.php?rid=3300349&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3y4h An article in the Journal Miner recently highlighted the fact that many people are living longer, healthier and more productive lives thanks to medical innovation and research... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3300349 Wed, 24 Feb 2010 12:00:00 +0100 3300349 Amylin And Takeda Announce Decision To Advance Development Of Pramlintide/Metreleptin Combination Treatment For Obesity http://www.medworm.com/index.php?rid=3300352&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3y3T Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Takeda Pharmaceutical Company Limited (TSE: 4502) announced that the companies have selected the combination treatment of pramlintide, an analog of the natural hormone amylin, and metreleptin, an analog of the natural hormone leptin, for advancement toward Phase 3 development... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3300352 Wed, 24 Feb 2010 11:00:00 +0100 3300352 PAREXEL Opens New Early Phase Unit In South Africa, Expanding Capabilities To Support Clients In Accelerating Development http://www.medworm.com/index.php?rid=3300351&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3y3S PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services provider, announced that it has expanded its capabilities through the opening of a new early phase unit in Port Elizabeth, South Africa. The Port Elizabeth unit has added more than 40 beds to PAREXEL's global early phase capacity of over 580 beds, which is among the largest capacities worldwide... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3300351 Wed, 24 Feb 2010 11:00:00 +0100 3300351 Catalyst Pharmaceutical Partners And The National Institute On Drug Abuse Plan To Initiate U.S. Phase II(b) Clinical Trial For Cocaine Addiction http://www.medworm.com/index.php?rid=3300350&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3y3Q Catalyst Pharmaceutical Partners, Inc. (NasdaqCM: CPRX) announced that it has signed a non-binding Letter of Intent with the National Institute on Drug Abuse (NIDA) to conduct a U.S. Phase II(b) clinical trial evaluating CPP-109, Catalyst's formulation of vigabatrin, for the treatment of cocaine addiction... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3300350 Wed, 24 Feb 2010 11:00:00 +0100 3300350 Have You Kept Your New Years Resolutions? The Market Access Summit, 2-3 June, Philadelphia May Help You Get Back On Track http://www.medworm.com/index.php?rid=3296708&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xXd Apparently this week is the week most people drop the promises they made to their selves just a few weeks ago. Lasting change is difficult to maintain, personally and professionally. Indeed, how long have yours lasted? Now, we can't exactly come to your house and stop you drinking that third glass of red wine of the evening - but we can definitely help with your professional resolutions... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3296708 Mon, 22 Feb 2010 13:00:00 +0100 3296708 GlaxoSmithKline And XenoPort Receive FDA Complete Response Letter For Horizant™ (GSK1838262/XP13512) For RLS http://www.medworm.com/index.php?rid=3289775&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xV4 GlaxoSmithKline (NYSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) Wednesday received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Horizant™(gabapentin enacarbil) Extended-Release Tablets, an investigational non-dopaminergic treatment for moderate-to-severe primary Restless Legs Syndrome (RLS)... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3289775 Sat, 20 Feb 2010 10:00:00 +0100 3289775 GSK Statement On FDA's Proposed Label Revisions For Some Asthma Medicines http://www.medworm.com/index.php?rid=3289774&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xV3 GlaxoSmithKline is reviewing label changes proposed by the US Food and Drug Administration (FDA) for asthma medications containing long-acting beta-agonists (LABAs), such as GSK's Advair (salmeterol / fluticasone propionate). GSK and makers of the other affected medicines containing LABAs have 30 days to agree with the proposed changes or state why they are not warranted... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3289774 Sat, 20 Feb 2010 10:00:00 +0100 3289774 Jazz Pharmaceuticals Announces FDA Acceptance Of Its New Drug Application For JZP-6 (sodium Oxybate) For The Treatment Of Fibromyalgia http://www.medworm.com/index.php?rid=3289779&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xTG Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for JZP-6 (sodium oxybate) for the treatment of fibromyalgia. Based on a standard 10-month review, the target date for the FDA to complete its review of the NDA under the Prescription Drug User Fee Act (PDUFA) is October 11, 2010... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3289779 Sat, 20 Feb 2010 09:00:00 +0100 3289779 GSK Statement On FDA's Proposed Label Revisions For Some Asthma Medicines http://www.medworm.com/index.php?rid=3289778&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xTF GlaxoSmithKline (NYSE: GSK) is reviewing label changes proposed by the US Food and Drug Administration (FDA) for asthma medications containing long-acting beta-agonists (LABAs), such as GSK's Advair (salmeterol / fluticasone propionate). GSK and makers of the other affected medicines containing LABAs have 30 days to agree with the proposed changes or state why they are not warranted... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3289778 Sat, 20 Feb 2010 09:00:00 +0100 3289778 Epeius Biotechnologies Corporation Expands Its Rexin-G Production Facilities In Southern California http://www.medworm.com/index.php?rid=3289777&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xTC Epeius Biotechnologies announces the completion of the design engineering and construction phase of a state-of-the-art Vector Production Unit (VPU) for the commercial manufacturing of its advanced targeted genetic medicines... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3289777 Sat, 20 Feb 2010 09:00:00 +0100 3289777 Many Americans Enjoying Longer, Healthier Lives Due To Medical Innovation And New Therapies http://www.medworm.com/index.php?rid=3289776&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xTz An article that recently appeared in El Tejano Magazine highlighted the fact that many Americans are living longer, healthier and more productive lives because of medical innovation and research. America's pharmaceutical research and biotechnology companies are leading the charge... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3289776 Sat, 20 Feb 2010 09:00:00 +0100 3289776 UCSF Enters Drug Discovery Agreement With Genentech http://www.medworm.com/index.php?rid=3289780&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xRG The University of California, San Francisco has signed a partnership agreement with Genentech, Inc., a wholly owned member of the Roche Group, to discover and develop drug candidates for neurodegenerative diseases. Through the agreement, Genentech will provide funding and its research acumen in neuroscience and will collaborate with UCSF to identify small molecules... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3289780 Sat, 20 Feb 2010 08:00:00 +0100 3289780 Preliminary Data From Roche ATHENA Cervical Cancer Trial Support Value Of Human Papillomavirus Genotyping http://www.medworm.com/index.php?rid=3286053&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xQH Roche Molecular Systems, Inc. (SIX: RO, ROG; OTCQX: RHHBY) announced that preliminary data from its ATHENA (Addressing THE Need for Advanced HPV Diagnostics) trial support the importance of screening for human papillomavirus (HPV) genotypes that put women at highest risk for developing cervical cancer. ATHENA is a prospective, double-blind, multi-centered, 47,000-patient, U.S... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3286053 Fri, 19 Feb 2010 11:00:00 +0100 3286053 Applications Sought For RPS Conference 2010 Practice Research Award, UK http://www.medworm.com/index.php?rid=3286054&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xQf Nominations or applications for the Practice Research Award at the Royal Pharmaceutical Society's Conference 2010 are invited for consideration by the conference Practice Research Panel... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3286054 Fri, 19 Feb 2010 09:00:00 +0100 3286054 AAAS Scientific Freedom And Responsibility Award To Be Presented To Dr. Nancy Olivieri http://www.medworm.com/index.php?rid=3286055&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xPb The 2009 American Association for the Advancement of Science (AAAS) Scientific Freedom and Responsibility Award will honor Dr. Nancy Olivieri of the University of Toronto "for her indefatigable determination that patient safety and research integrity come before institutional and commercial interests." Dr... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3286055 Fri, 19 Feb 2010 08:00:00 +0100 3286055 Making Vaccines Stable At Tropical Temperatures http://www.medworm.com/index.php?rid=3281783&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xNj A cheap and simple way of making vaccines stable - even at tropical temperatures - has been proven to work by scientists at Oxford University. The British technology, developed by specialist manufacturer Nova Bio-Pharma Technologies, removes the need for fridges, freezers and associated health infrastructure... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3281783 Thu, 18 Feb 2010 12:00:00 +0100 3281783 Media Examine Fight Against Counterfeit Drugs http://www.medworm.com/index.php?rid=3281782&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xN4 The Wall Street Journal reports on the recent shutdown of a counterfeit drug ring in Syria, while highlighting a broader problem with counterfeit medicines in the Middle East. Authorities intercepted "millions of dollars worth of breast cancer, leukemia and other medicines ... At least 65 people were detained; it couldn't be learned if they were charged... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3281782 Thu, 18 Feb 2010 12:00:00 +0100 3281782 Otonomy Receives FDA Clearance To Initiate Clinical Trial In Patients With Meniere's Disease http://www.medworm.com/index.php?rid=3281784&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xMk Otonomy, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance of the company's Investigational New Drug (IND) application for the clinical trial of OTO-104 in patients with Meniere's disease, a debilitating disorder of the inner ear affecting balance and hearing... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3281784 Thu, 18 Feb 2010 11:00:00 +0100 3281784 Mission Pharmacal Launches New Formulation Of Kidney Stone Treatment, Urocit®-K 15 Meq http://www.medworm.com/index.php?rid=3281785&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xMh Mission Pharmacal Company announced the introduction of the Urocit®-K 15 mEq (potassium citrate) Extended-release tablet. The new formulation builds on the heritage of Urocit-K with a maximum-strength alkalinizing agent to help prevent kidney stone recurrence in more than 90 percent of patients... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3281785 Thu, 18 Feb 2010 10:00:00 +0100 3281785 Cellular Mechanism That Protects Against Disease Discovered By OHSU Researchers http://www.medworm.com/index.php?rid=3274556&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xGh Researchers at Oregon Health & Science University have discovered a new mechanism within human cells that constantly protects us against disease. P. Michael Conn, Ph.D., a researcher at the OHSU Oregon National Primate Research Center directed the work. The findings are reported in the Feb. 15 issue of the journal Proceedings of the National Academy of Sciences... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3274556 Tue, 16 Feb 2010 10:00:00 +0100 3274556 Max Neeman International Expands Specialized Surgical Team For Clinical Trials http://www.medworm.com/index.php?rid=3274557&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xG8 Max Neeman International, a leading Indian CRO, has formed an exclusive team of India's finest, most experienced Physicians to conduct Minimally Invasive Surgery Studies. The team consists of the best Minimal Access Surgeons in the country who have performed more than 25,000 procedures combined... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3274557 Tue, 16 Feb 2010 09:00:00 +0100 3274557 PhRMA's Tauzin Quits Amid Talk That White House Deal Caused Tension Within Organization http://www.medworm.com/index.php?rid=3272013&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xCs Former congressman and powerful lobbyist Billy Tauzin is resigning as head of the pharmaceutical industry trade group after a deal he helped broker with the White House on health reform strained relationships inside the group... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3272013 Mon, 15 Feb 2010 08:00:00 +0100 3272013 Therapeutic Cells Derived From Reprogrammed (iPS) Stem Cells Display Early Aging http://www.medworm.com/index.php?rid=3265116&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xym Advanced Cell Technology, Inc. (OTCBB: ACTC) reported that a range of therapeutic cell types obtained from induced pluripotent stem (iPS) cells exhibit abnormal expansion and early cellular aging... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3265116 Fri, 12 Feb 2010 10:00:00 +0100 3265116 NewLink Genetics Receives Special Protocol Assessment Approval From FDA For Pivotal Phase 3 Trial In Pancreatic Cancer http://www.medworm.com/index.php?rid=3265117&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xy5 NewLink Genetics Corporation announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process for a pivotal Phase 3 trial of its HyperAcute immunotherapy in pancreatic cancer. Pancreatic cancer is highly lethal and is currently an area of very significant unmet medical need... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3265117 Fri, 12 Feb 2010 09:00:00 +0100 3265117 Today's OpEds: Prescriptions For Health Reform http://www.medworm.com/index.php?rid=3261091&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xw7 Ten GOP Health Ideas For Obama The Wall Street JournalThe best ideas out there are not those that were passed by the House and Senate last year, which consist of more spending, more regulations and more bureaucracy. If the president is serious about building a system that delivers more quality choices at lower cost for every American, here's where he should start (Newt Gingrich and John C... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3261091 Thu, 11 Feb 2010 12:00:00 +0100 3261091 Kinexus Announces The Launch Of A New Protein Kinase Microarray http://www.medworm.com/index.php?rid=3261094&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xvx Kinexus Bioinformatics Corporation announced the commercial release of its novel Protein Kinase Microarray with 200 recombinant human protein kinases for screening... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3261094 Thu, 11 Feb 2010 10:00:00 +0100 3261094 Naurex Inc. Reports Positive Top-Line Phase I Results For Its Novel Mechanism NMDA Receptor Modulator GLYX-13 In Treatment-Resistant Depression http://www.medworm.com/index.php?rid=3261093&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xvv Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel glycine site functional partial agonist (GFPA) NMDA receptor modulators, today reported positive top-line results from its Phase I clinical trial of lead compound GLYX-13. GLYX-13 is a GFPA selective modulator of the NMDA receptor... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3261093 Thu, 11 Feb 2010 10:00:00 +0100 3261093 Raptor Pharmaceutical Corp. To Present Cystinosis Research At Lysosomal Disease Network's 2010 WORLD Symposium http://www.medworm.com/index.php?rid=3261092&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xvr Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTP), announced the presentation of cystinosis data at the Annual Lysosomal Disease Network WORLD Symposium 2010, being held February 10-12 in Miami, Florida... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3261092 Thu, 11 Feb 2010 10:00:00 +0100 3261092 Findings Of Poor Quality Malaria Drugs In Africa Add To Artemisinin-Resistance Worries http://www.medworm.com/index.php?rid=3257027&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xst A study released on Monday found that between 26 percent and 44 percent of artemisinin-based malaria drugs sold in Madagascar, Senegal and Uganda "failed quality testing" because of impurities or insufficient amounts of active ingredient, the Associated Press reports. The study, which was conducted by the nongovernmental U.S... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3257027 Wed, 10 Feb 2010 12:00:00 +0100 3257027 Palatin Technologies, Inc. Announces Dosing Of Subcutaneous Bremelanotide Trial In Men http://www.medworm.com/index.php?rid=3257028&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xr6 Palatin Technologies, Inc. (NYSE Amex: PTN) announced the completion of first cohort dosing in a placebo-controlled, multiple dose study of bremelanotide, its experimental treatment for sexual dysfunction. The primary endpoint in this double-blind safety study is evaluation of blood pressure effects of subcutaneous bremelanotide in men between 45 and 65 years old... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3257028 Wed, 10 Feb 2010 09:00:00 +0100 3257028 Analysts: If Health Reform Fails, Expect More Industry Mergers http://www.medworm.com/index.php?rid=3252835&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xph News outlets report on how the fate of the health care overhaul might affect health industry mergers and biotech firms... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3252835 Tue, 09 Feb 2010 12:00:00 +0100 3252835 Access To Private Drugs In Public Hospitals http://www.medworm.com/index.php?rid=3252836&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xpB Governments are under increasing pressure to provide access to expensive new drugs. Canadian patients who want access to drugs that are not publicly insured are seeking to pay for these drugs within public hospitals, states an article in CMAJ (Canadian Medical Association Journal) This analysis by Colleen M... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3252836 Tue, 09 Feb 2010 11:00:00 +0100 3252836 Medical Breakthroughs With Biotechnology http://www.medworm.com/index.php?rid=3252837&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xnK A recent article in the Scandia Journal reported that biotechnology is helping to improve our knowledge of many devastating illnesses, and has armed patients and their doctors with exciting new diagnostics and treatments to battle disease... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3252837 Tue, 09 Feb 2010 09:00:00 +0100 3252837 APCER Pharma Announces That LPC Pharma Group To Outsource Pharmacovigilance/Drug Safety To APCER http://www.medworm.com/index.php?rid=3252838&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xmW APCER Pharma announced that LPC Pharma Group is outsourcing its http://www.pharmacovigilance/drug safety operations to APCER. APCER is a leading global provider of comprehensive drug safety, regulatory services and risk management programs for pharmaceutical, biotechnology, medical device and consumer products companies... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3252838 Tue, 09 Feb 2010 08:00:00 +0100 3252838 Gaining Market Access By Providing Value For Money http://www.medworm.com/index.php?rid=3249618&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xmN Cost-effectiveness research will become more important as EU responsibility for the pharmaceutical sector moves to the Health and Consumer policy directorate, Lynne Taylor and Peter Mansell report... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3249618 Mon, 08 Feb 2010 12:00:00 +0100 3249618 BIO Joins Stakeholders In Expressing Concerns With Efforts To Restrict Gene Patenting http://www.medworm.com/index.php?rid=3249617&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xmL The Biotechnology Industry Organization (BIO) released a letter to Health and Human Services Secretary Kathleen Sebelius regarding the potentially harmful recommendations of the Secretary's Advisory Committee on Genetics, Health and Society (SACGHS) in its Report on Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3249617 Mon, 08 Feb 2010 12:00:00 +0100 3249617 Health Bill Stall Creates Uncertainty For Drug Makers http://www.medworm.com/index.php?rid=3249619&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xkD "With the possible demise of health care legislation, getting back to business as usual may not be the best thing for the nation's drug makers," The New York Times reports... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3249619 Mon, 08 Feb 2010 08:00:00 +0100 3249619 Launch Of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 Mg) In France For The Treatment Of Prostate Cancer http://www.medworm.com/index.php?rid=3245799&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xk7 Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announce the launch by Ipsen in France of Decapeptyl(R) LP 22... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3245799 Sat, 06 Feb 2010 09:00:00 +0100 3245799 NovaBay Pharmaceuticals To Present At The 2010 BIO CEO & Investor Conference http://www.medworm.com/index.php?rid=3245800&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xjk NovaBay Pharmaceuticals, Inc. (NYSE Amex: NBY), a clinical stage biopharmaceutical company developing first-in-class, anti-infective compounds in the treatment and prevention of antibiotic-resistant infections, today announced that Ron Najafi, Ph.D., Chairman and Chief Executive Officer, will deliver a corporate presentation at the 12th Annual BIO CEO & Investor Conference on Tuesday, Feb... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3245800 Sat, 06 Feb 2010 02:00:00 +0100 3245800 BIO Proposes Second Wave Of Advanced Biofuel Commercialization Policy To Stimulate Job Creation http://www.medworm.com/index.php?rid=3245801&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xhJ Additional Congressional action is needed to follow through on the Obama administration's recently announced initiative to rapidly build an integrated value chain for the bioeconomy, create jobs and kick start economic growth. The Biotechnology Industry Organization (BIO) today released proposed policy options that provide needed incentives to support U.S... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3245801 Fri, 05 Feb 2010 18:00:00 +0100 3245801 Drug Company CEOs Under Pressure http://www.medworm.com/index.php?rid=3241977&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xcT News outlets feature profiles and opinions of the CEOs of some of the largest American drug manufacturers. Dow Jones Newswires/The Wall Street Journal on Severin Schwan, chief executive of Swiss pharmaceutical company Roche Holding AG: "'It is difficult to gauge the impact of the planned U.S... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3241977 Thu, 04 Feb 2010 13:00:00 +0100 3241977 BIO Welcomes Obama Proposal To Achieve Advanced Biofuels Targets, Final Rules On Renewable Fuel Standard http://www.medworm.com/index.php?rid=3237945&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xd8 The Obama administration's new biofuels initiative is a much-needed step in federal coordination that can help pioneer companies secure the investment needed to build large-scale advanced biofuels production facilities... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3237945 Thu, 04 Feb 2010 12:00:00 +0100 3237945 Court Weighs Patents For Human Genes http://www.medworm.com/index.php?rid=3237946&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xcV The American Civil Liberties Union has sued a genetics company that holds patents on breast- and ovarian-cancer-causing genes, saying their claims on the two genes hinders further research by other companies and scientists, the Associated Press/CBS News reports. ACLU lawyers have argued the discovery of the genes should not be rewarded with a patent because each is an "ancient secret of nature... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3237946 Thu, 04 Feb 2010 11:00:00 +0100 3237946 Cymbalta(R) Significantly Reduced Chronic Low Back Pain In New Study http://www.medworm.com/index.php?rid=3237949&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xcd In a new study, 60 mg of Cymbalta(R) (duloxetine HCl) taken once daily significantly reduced chronic low back pain, as measured by the Brief Pain Inventory (BPI) average pain rating, compared with placebo.(1) The data were presented at the annual meeting of the American Academy of Pain Medicine (AAPM) in San Antonio, Texas... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3237949 Thu, 04 Feb 2010 10:00:00 +0100 3237949 Keryx Biopharmaceuticals Announces Protocol Assessment Agreement With FDA For Phase 3 Trial Of KRX-0401 (Perifosine) To Treat Colorectal Cancer http://www.medworm.com/index.php?rid=3237948&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xbW Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) on the design of a Phase 3 trial for its PI3K/Akt pathway inhibitor, KRX-0401 (perifosine), in patients with refractory metastatic colorectal cancer... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3237948 Thu, 04 Feb 2010 10:00:00 +0100 3237948 SOMA 250 MG Shown To Significantly Improve Functionality And Reduce Disability In Patients With Low Back Pain In Three Days http://www.medworm.com/index.php?rid=3237947&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3xbV A recent analysis of two pivotal clinical trials in patients with acute low back pain (ALBP) who were treated with SOMA® (carisoprodol) 250 mg showed significantly improved functionality and reduced disability after three days of treatment, as measured by the Roland-Morris Disability Questionnaire (RMDQ)... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3237947 Thu, 04 Feb 2010 10:00:00 +0100 3237947 Vantia Therapeutics' Lead Candidate VA106483 Enters Phase IIb Trial For Nocturia http://www.medworm.com/index.php?rid=3233946&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3x8g Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, announces it has begun its planned Phase IIb trial of its lead development compound VA106483 for nocturia. The study is a randomised, double-blind, placebo-controlled study and is expected to recruit approximately 120 male patients at 20 centres in the US... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3233946 Wed, 03 Feb 2010 11:00:00 +0100 3233946 Lawmakers Seek Details Of Obama's Closed-Door Meetings With Health Industry Groups http://www.medworm.com/index.php?rid=3229795&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3x5q "In a rare display of bipartisanship,... Rep. Henry Waxman (D-Calif.), chairman of the House Energy and Commerce Committee, said he'd help Dr. Michael Burgess (R-Texas) seek information on the names of representatives from the pharmaceutical, device, hospital, doctor, and insurance sectors, who met with White House officials regarding healthcare reform," Medpage Today/ABC News reports... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3229795 Tue, 02 Feb 2010 12:00:00 +0100 3229795 Romark Initiates Clinical Trial Of Alinia For Treatment Of Influenza http://www.medworm.com/index.php?rid=3229796&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3x4t Romark Laboratories announced that it has initiated enrollment of patients in a clinical trial of Alinia® (nitazoxanide) for treating acute uncomplicated influenza including illness caused by the currently circulating H1N1 strain... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3229796 Tue, 02 Feb 2010 09:00:00 +0100 3229796 Market Access Europe Conference, March 2010 http://www.medworm.com/index.php?rid=3229797&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3x3X Diminishing market access has become one of the central challenges for the pharmaceutical industry. Whereas regulatory agency approval used to be the final hurdle in drug development, now pharmaceutical companies must negotiate an obstacle course of reimbursement dossiers, cost-effectiveness studies, decentralized health authorities, and post-launch observational research... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3229797 Mon, 01 Feb 2010 18:00:00 +0100 3229797 Best Practice In Clinical Site Selection And Performance Management Conference, March, 2010 http://www.medworm.com/index.php?rid=3226248&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3x3L Develop and implement your tactics to enhance the performance of your site pool to ensure the time, cost and quality objectives of your global trial. Conference dates: 17th-18th March, 2010 Venue: Radisson Royal, Brussels, Belgium This event will look at the principal factors that affect the performance of clinical sites when conducting trials... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3226248 Mon, 01 Feb 2010 13:00:00 +0100 3226248 UCB Accelerates Transition To Become Patient-centric Global Biopharmaceutical Leader With Decision To Exit The Primary Care Market In The U.S. http://www.medworm.com/index.php?rid=3226249&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3x3D UCB announced that it plans to accelerate its U.S. transition to a purely specialty-focused biopharmaceutical company and will exit the primary care market in the U.S., effective 1 March 2010. This strategic decision impacts the reported 2009 net profit with one-time restructuring charges, while freeing more resources for core products... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3226249 Mon, 01 Feb 2010 12:00:00 +0100 3226249 BIO Welcomes President Obama's Remarks On Advanced Biofuels http://www.medworm.com/index.php?rid=3222185&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wYk The United States can lead the world in deploying advanced biotechnology for biofuels and create thousands of new jobs by implementing policies to support the emerging industry... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3222185 Fri, 29 Jan 2010 18:00:00 +0100 3222185 BIO Debuts Livestock Biotech Summit http://www.medworm.com/index.php?rid=3222186&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wYj The Biotechnology Industry Organization (BIO) announced today its newest conference, the Livestock Biotech Summit, scheduled for September 28-30, 2010, in Sioux Falls, S.D... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3222186 Fri, 29 Jan 2010 17:00:00 +0100 3222186 Omeros Announces National Institute On Drug Abuse's Support For Phase 2 Clinical Study In Addiction Program http://www.medworm.com/index.php?rid=3218758&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wWM Omeros Corporation (Nasdaq: OMER) announced that the National Institute on Drug Abuse (NIDA) is providing support for the Company's Addiction program. NIDA will fund substantially all of the costs of a Phase 2 clinical study to be conducted by New York State Psychiatric Institute researchers... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3218758 Fri, 29 Jan 2010 10:00:00 +0100 3218758 Duke To Lead Effort To Better Understand The Role Of Rare Genetic Variation In Clozapine-induced Agranulocytosis Using Whole Genome Sequencing http://www.medworm.com/index.php?rid=3218759&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wVL The International Serious Adverse Events Consortium (SAEC) has announced that it will collaborate with Duke University's Center for Human Genome Variation to research the genetics of Clozapine-induced agranulocytosis (CIA), with the goal of identifying potential rare genetic variants predictive of this serious drug induced adverse event... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3218759 Fri, 29 Jan 2010 08:00:00 +0100 3218759 Gilead Sciences Announces Notification Of ANDA Filing For Viread(R) http://www.medworm.com/index.php?rid=3218760&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wVK Gilead Sciences, Inc. (Nasdaq:GILD) today announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) requesting permission to manufacture and market a generic version of Viread® (tenofovir disoproxil fumarate)... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3218760 Thu, 28 Jan 2010 23:00:00 +0100 3218760 New Association Of The British Pharmaceutical Industry President Announced http://www.medworm.com/index.php?rid=3218761&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wV8 Simon Jose, Senior Vice President and General Manager of GlaxoSmithKline (GSK) UK Pharmaceuticals, has been named as President Designate of the Association of the British Pharmaceutical Industry (ABPI). Simon will take over from current ABPI President, Chris Brinsmead of AstraZeneca (UK), on 28 April this year... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3218761 Thu, 28 Jan 2010 16:00:00 +0100 3218761 African Vaccine Maker Plans To Increase Production Capacity Sevenfold By 2013 http://www.medworm.com/index.php?rid=3214730&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wTF Biovac Institute, a South African vaccine maker, said Monday that it is working with other major pharmaceutical firms to increase its annual capacity sevenfold to 35 million doses by 2013, Reuters reports. Morena Makhoana, the company's deputy chief executive, said that 25 million of those doses will remain in Africa... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3214730 Thu, 28 Jan 2010 12:00:00 +0100 3214730 Health Care Stocks Gain As Reform Falters http://www.medworm.com/index.php?rid=3214731&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wTk "Health care stocks lagged the broader market's recovery in 2009," Forbes reports. "The possibility of a public option or any other legislation that might squeeze corporate profits 'scared the dickens out of people' in 2009, says Peter Tuz, president of money manager Chase Investment Counsel... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3214731 Thu, 28 Jan 2010 11:00:00 +0100 3214731 IR Biosciences' ImmuneRegen (OTCBB: IRBS) Getting Attention For Its Adult Stem Cell Active Compound http://www.medworm.com/index.php?rid=3210451&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wQw BioMedReports... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3210451 Wed, 27 Jan 2010 11:00:00 +0100 3210451 European Medicines Agency Launches Consultation On Its Road Map To 2015 http://www.medworm.com/index.php?rid=3210452&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wNL The European Medicines Agency has launched a three-month public consultation on its Road Map to 2015, coinciding with its 15th anniversary on 26 January 2010 European and international partners, stakeholders, including patients' and doctors' organisations as well as pharmaceutical industry, and the public are invited to make their views known on the Agency's future strategic ... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3210452 Wed, 27 Jan 2010 08:00:00 +0100 3210452 New 340B Program At NorthShore Health Centers Offers Prescription Drug Discounts Of Up To 60 Percent http://www.medworm.com/index.php?rid=3210453&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wNv NorthShore Health Centers announced a new program in partnership with healthcare technology company SUNRx that will help provide discounted prescription drugs to low-income patients who may be struggling to afford medications... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3210453 Wed, 27 Jan 2010 01:00:00 +0100 3210453 Researchers Simplify Dangerously Confusing Warnings On Prescription Bottles http://www.medworm.com/index.php?rid=3206967&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wML Replacing confusing language and icons on standard warnings labels for prescription medicine and listing only the most important warnings could make a big difference in how well patients understand the instructions that are critical to their health, according to a new study from Northwestern University Feinberg School of Medicine... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3206967 Tue, 26 Jan 2010 12:00:00 +0100 3206967 State News: New York Governor Wants Regulation On Rx Gifts To Doctors And Other State News http://www.medworm.com/index.php?rid=3206968&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wMf The Associated Press/CNBC reports that New York Gov. David Paterson is "proposing new, tougher prohibitions on pharmaceutical companies, restricting them from dispensing gifts and misleading production information to doctors while promoting the use of specific drugs." Nine states have similar legislation... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3206968 Tue, 26 Jan 2010 10:00:00 +0100 3206968 Poniard Pharmaceuticals Announces Phase 2 Trial Of Picoplatin In Metastatic Colorectal Cancer Meets Primary Endpoint And Study Objectives http://www.medworm.com/index.php?rid=3206969&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wLm Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, announced final data from a randomized, controlled Phase 2 trial of picoplatin in metastatic colorectal cancer (CRC) patients... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3206969 Tue, 26 Jan 2010 09:00:00 +0100 3206969 Court Of Appeals Affirms Favorable Decision Regarding Generic Prevacid(R) SoluTab http://www.medworm.com/index.php?rid=3203066&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wKp Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed a Nov. 10, 2009, District Court decision that the Company's generic version of Takeda's Prevacid® (lansoprazole) SoluTab does not infringe U.S. Patent No. 5,464,632... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3203066 Mon, 25 Jan 2010 11:00:00 +0100 3203066 New Appointments To The British Pharmacopoeia Commission http://www.medworm.com/index.php?rid=3199492&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wFV The British Pharmacopoeia (BP) Commission and the Appointments Commission are pleased to announce the appointment and re-appointment of members to the BP Commission. The BP Commission is responsible for preparing new editions of the BP and the BP (Veterinary) and for keeping them up to date... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3199492 Fri, 22 Jan 2010 15:00:00 +0100 3199492 Reuters Examines Chronic Disease In Developing Countries, Future Of Drug Prices http://www.medworm.com/index.php?rid=3199493&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wFw "Global health projections leave little doubt that chronic diseases are rapidly overtaking infectious diseases, such as malaria, AIDS and tuberculosis (TB), as the world's biggest killers - a shift emphasized by a recent World Health Organization (WHO) report on global health risks," Reuters writes in a story analyzing the future of drug pricing in the developing world... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3199493 Fri, 22 Jan 2010 13:00:00 +0100 3199493 116th Annual Meeting To Showcase Experts On Emerging Issues Within The Beauty Industry http://www.medworm.com/index.php?rid=3195995&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wFy The Personal Care Products Council will host its Annual Meeting Feb. 23-25 at the Boca Raton Resort & Club in Boca Raton, Fla. The program features external and industry experts with uniqueperspectives on the challenges U.S. companies face in today's complex, changing and globally competitive business environment... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3195995 Fri, 22 Jan 2010 10:00:00 +0100 3195995 NSF Grant To Launch World's First Open-Source Genetic Parts Production Facility http://www.medworm.com/index.php?rid=3195996&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wD8 With seed money from the National Science Foundation (NSF), bioengineers from the University of California, Berkeley, and Stanford University are ramping up efforts to characterize the thousands of control elements critical to the engineering of microbes so that eventually, researchers can mix and match these "DNA parts" in synthetic organisms to produce new drugs, fuels or chemicals... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3195996 Fri, 22 Jan 2010 08:00:00 +0100 3195996 BIO Applauds Intellectual Property Pool To Encourage Research To Accelerate Medical Therapies For Neglected Diseases http://www.medworm.com/index.php?rid=3195997&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wCk The Biotechnology Industry Organization (BIO) applauds the joint efforts of BIO members GlaxoSmithKline and Alnylam Pharmaceuticals to encourage research to accelerate medical therapies for neglected diseases and today's announcement of the selection of BIO Ventures for Global Health (BVGH) as the administrator of the Intellectual Property (IP) Pool... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3195997 Thu, 21 Jan 2010 17:00:00 +0100 3195997 Janssen-Cilag International NV Withdraws Its Marketing Authorisation Application For Comfyde (Carisbamate), Europe http://www.medworm.com/index.php?rid=3191591&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wB4 The European Medicines Agency has been formally notified by Janssen-Cilag International NV of its decision to withdraw its application for a centralised marketing authorisation for the medicine Comfyde (carisbamate) 100mg, 200mg, 400mg and 600mg film-coated tablets... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3191591 Thu, 21 Jan 2010 10:00:00 +0100 3191591 Medtronic Seeking Long-Distance Runners Who Benefit From Medical Technology http://www.medworm.com/index.php?rid=3187531&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wwN Medtronic (NYSE: MDT) announced it is recruiting runners from around the world who benefit from medical technology to participate in the fifth annual Medtronic Global Heroes program... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3187531 Wed, 20 Jan 2010 10:00:00 +0100 3187531 Zebrafish Behavior Monitoring System Could Boost Drug Discovery: UBC-Harvard Research http://www.medworm.com/index.php?rid=3187532&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wwx Researchers from the University of British Columbia and Harvard University have co-developed a system that captures on video and barcodes the behavioral responses of zebrafish to chemical compounds on a large scale. The approach could dramatically speed up the discovery of new psychiatric drugs... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3187532 Wed, 20 Jan 2010 09:00:00 +0100 3187532 Top 5 New Years Resolutions For Pharma Sales Managers http://www.medworm.com/index.php?rid=3184169&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wt7 It's that time of year and resolving to make a change to your lifestyle is practically mandatory. But how long will you keep it up for? Lasting change is difficult to maintain, personally and professionally. Now, we can't exactly come to your house and stop you drinking that third glass of red wine of the evening - but we can definitely help with your professional resolutions... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3184169 Mon, 18 Jan 2010 16:00:00 +0100 3184169 Obama Signals Interest In Reducing The Protections For Biologic Drugs http://www.medworm.com/index.php?rid=3181160&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wrn Lobbyists for generic biologic drugmakers are fighting to undercut a provision in the proposed health overhaul that would protect brand-name pharmaceutical companies from lower-cost, generic competition over new products for 12 years, the Associated Press reports. The generic companies have friends in high places: "White House officials and Rep. Henry Waxman, D-Calif... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3181160 Mon, 18 Jan 2010 09:00:00 +0100 3181160 Key Event Occurs In GenVec's PACT Trial http://www.medworm.com/index.php?rid=3177787&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wqJ GenVec, Inc. (Nasdaq: GNVC) announced that 184 events (deaths) have occurred in its ongoing Phase III Pancreatic Cancer Clinical Trial with TNFerade™ (PACT) in patients with locally advanced pancreatic cancer. This event, which represents two-thirds of the total events expected in the trial, triggers the next interim analysis of overall survival in the trial... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3177787 Sat, 16 Jan 2010 09:00:00 +0100 3177787 FTC Wants To Ban 'Pay-To-Delay' Settlements Related To Generic Drugs http://www.medworm.com/index.php?rid=3177788&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wnK The Associated Press/USA Today: "The Federal Trade Commission says patent settlements between drugmakers that cost U.S. consumers billions each year are on the rise. The agency reported Wednesday that the number of lucrative settlements between brand-name and generic drug companies rose to 19 last year from 16 in 2008 and 14 the year before... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3177788 Fri, 15 Jan 2010 12:00:00 +0100 3177788 Multiple Issues Still On The Table In House-Senate Health Bill Negotiations http://www.medworm.com/index.php?rid=3174105&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wnx Reports explored contentious policies in the House and Senate versions of the health-overhaul legislation that are part of the final negotiations. The New York Times: One important - and until recently, rarely discussed - reform issue that splits Senate and House negotiators is states' roles in implementing the health care overhaul... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3174105 Fri, 15 Jan 2010 11:00:00 +0100 3174105 BIO Asks California For Consistent, Accurate Accounting Of Emissions Under Cap-and-Trade Rules http://www.medworm.com/index.php?rid=3174106&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3whz California's cap-and-trade regulations should recognize that using biomass for biofuels is carbon neutral and does not contribute to global warming. The Biotechnology Industry Organization (BIO) yesterday submitted comments to the California Air Resources Board on its preliminary draft regulation for the state's Cap-and-Trade Program, which is scheduled for implementation in 2011... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3174106 Fri, 15 Jan 2010 09:00:00 +0100 3174106 GAO: Some Meds Had 'Extraordinary' Price Hikes Over Past Eight Years http://www.medworm.com/index.php?rid=3169614&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wfb A report from the Government Accountability Office (GAO) issued Monday finds that "[p]rices on a growing number of prescription medications have ballooned in recent years as consolidation in the drug industry leaves fewer companies manufacturing niche medications," The Associated Press reports... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3169614 Wed, 13 Jan 2010 13:00:00 +0100 3169614 Nektar Therapeutics Announces Positive Topline Results For NKTR-102 From First Stage Of Phase 2 Study In Platinum Resistant Ovarian Cancer http://www.medworm.com/index.php?rid=3165704&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wdd Nektar Therapeutics (Nasdaq: NKTR) announced preliminary results from the first stage of a two-stage Phase 2 clinical study evaluating NKTR-102 in women with platinum-resistant ovarian cancer. In the first stage of the study, 39 patients enrolled with platinum-resistant disease were evaluable for the primary endpoint of overall response rate using Gynecologic Cancer InterGroup (GCIG) criteria, i... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3165704 Wed, 13 Jan 2010 09:00:00 +0100 3165704 Local Head-Injury Patients Sought For Study Investigating Potential Treatment For Daytime Sleepiness http://www.medworm.com/index.php?rid=3165703&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wd9 Local patients are being sought for a national clinical research study currently investigating a study medication for people who have had a head injury, concussion or bump on the head and feel sleepy or tired during the day. According to the Centers for Disease Control and Prevention, head injury is one of the most common neurologic disorders, affecting around 1.5 million Americans every year... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3165703 Wed, 13 Jan 2010 09:00:00 +0100 3165703 FDA Unveils First Phase Of Transparency Initiative http://www.medworm.com/index.php?rid=3165705&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3wcR The U.S. Food and Drug Administration unveiled the first phase of its Transparency Initiative which is designed to explain agency operations, how it makes decisions, and the drug approval process... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3165705 Wed, 13 Jan 2010 08:00:00 +0100 3165705 VIVUS Announces Additional Results Of Phase 3 Avanafil Study In Erectile Dysfunction Showing Efficacy In 15 Minutes http://www.medworm.com/index.php?rid=3162088&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3w9j VIVUS, Inc. (Nasdaq: VVUS) announced new data from an analysis of the recently completed phase 3 study (REVIVE TA-301) of avanafil, an investigational drug candidate for the treatment of erectile dysfunction (ED)... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3162088 Tue, 12 Jan 2010 09:00:00 +0100 3162088 Trubion Pharmaceuticals, Inc. Announces Initiation Of A Phase 2 Study Of SBI-087 For The Treatment Of Rheumatoid Arthritis (RA) http://www.medworm.com/index.php?rid=3162087&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3w9c Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN) announced that its collaboration partner, Pfizer, has initiated a Phase 2 clinical trial of SBI-087 (PF-05230895) for the treatment of rheumatoid arthritis (RA). SBI-087 is a next-generation, humanized Small Modular ImmunoPharmaceutical (SMIP(TM)) protein therapeutic directed against the CD20 antigen... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3162087 Tue, 12 Jan 2010 09:00:00 +0100 3162087 Twelfth Annual BIO CEO & Investor Conference To Feature Clinical Thought Leaders, Industry Executives And Patient Groups http://www.medworm.com/index.php?rid=3158840&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3w85 The Biotechnology Industry Organization (BIO) announced the selection of therapeutic workshops to be presented at the Twelfth Annual BIO CEO & Investor Conference, taking place February 8-9 at the Waldorf=Astoria Hotel in New York City. Experts chosen to speak on these panels represent leading clinical institutions, medical foundations, and public and private biotechnology companies... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3158840 Mon, 11 Jan 2010 10:00:00 +0100 3158840 Moffitt Cancer Center Hosts Fourth-Annual Business Of Biotech Conference http://www.medworm.com/index.php?rid=3157139&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3w6t Moffitt Cancer Center will host its fourth-annual Business of Biotech: Vision + Drive = Innovation conference from 8 a.m. to 1 p.m. Feb. 1 in the Vincent A. Stabile Research Building, 12902 Magnolia Drive. "We are delighted Dr... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3157139 Sun, 10 Jan 2010 08:00:00 +0100 3157139 3SBio Inc. Applies For SFDA Registrational Trial For Feraheme(TM) http://www.medworm.com/index.php?rid=3155069&cid=s_22568_34_f&fid=22568&url=http%3A%2F%2Fmnt.to%2Ff%2F3w6L 3SBio Inc. (Nasdaq: SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, announced that it has submitted its application for a registrational clinical trial to the Chinese State Food and Drug Administration ("SFDA") for Feraheme (ferumoxytol) Injection for intravenous use... (Source: Pharma Industry News From Medical News Today) Pharma Industry News From Medical News Today news http://www.medworm.com/rss/comments.php?id=3155069 Sat, 09 Jan 2010 09:00:00 +0100 3155069